Hetlioz Suspension
Product Images NDC 43068-304

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Hetlioz (NDC 43068-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vanda Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hetlioz 01)

Chemical structure of tasimelteon, the active ingredient in Hetlioz LQ suspension. The diagram shows the molecular arrangement including a bicyclic furan ring linked to other chemical groups characteristic of tasimelteon's molecular formula.*

FDA Label Image

Figure A (Hetlioz 02)

An instructional diagram showing components of the Hetlioz LQ oral suspension packaging. It includes a bottle with a bottle cap, an oral dosing syringe labeled with syringe tip, barrel, and plunger, and a press-in bottle adapter. The diagram is labeled as Figure A.*

FDA Label Image

Figure B (Hetlioz 03)

An instructional illustration showing a hand holding a bottle of medication, shaking it with arrows indicating a shaking motion. A digital timer display shows 30 seconds, suggesting the bottle should be shaken for 30 seconds.*

FDA Label Image

Figure C (Hetlioz 04)

An instructional illustration showing a hand opening a bottle of Hetlioz LQ oral suspension by pushing down and twisting the cap. The diagram includes directional arrows indicating the steps to open the child-resistant closure.*

FDA Label Image

Figure D (Hetlioz 05)

An instructional illustration showing a hand placing a cap onto a bottle, indicating the proper way to close the bottle by pressing the cap down. The bottle has a blank rectangular label area.*

FDA Label Image

Figure E (Hetlioz 06)

An instructional illustration showing how to handle a medication bottle. The top image indicates twisting the cap to open or close the bottle, while the bottom image shows shaking the bottle gently from side to side. The diagram likely demonstrates proper use or preparation of Hetlioz LQ suspension.*

FDA Label Image

Figure F (Hetlioz 07)

An instructional illustration labeled Figure F showing a hand holding a syringe-like measuring device above an open bottle. The measuring device is marked with volume graduations from 1 mL to 5 mL, and an arrow indicates downward movement for measuring or dispensing liquid into the bottle.*

FDA Label Image

Figure G (Hetlioz 08)

An instructional diagram showing the method to draw liquid medication from a bottle into a syringe. The bottle is inverted above the syringe, which is held steady by hands, with a close-up inset emphasizing the connection between the syringe tip and the bottle opening.*

FDA Label Image

Figure H (Hetlioz 09)

An instructional illustration showing how to use the Hetlioz LQ suspension oral bottle. The left side depicts a syringe drawing medication from an open bottle. The right side shows a hand twisting the child-resistant cap on the bottle.*

FDA Label Image

Figure I (Hetlioz 10)

An instructional diagram showing a person receiving oral medication via a syringe. The syringe is marked with volume measurements from 1 mL to 5 mL and is being held by another hand administering the dose into the mouth of the person.*

FDA Label Image

Figure J (Hetlioz 11)

Illustration showing handwashing and rinsing instructions for a dosing syringe under running tap water. The image depicts holding a syringe under a faucet with water flowing to clean it, emphasizing hygiene for oral administration preparation.*

FDA Label Image

20 mg Bottle (composite) (Hetlioz 12)

Label for Hetlioz (tasimelteon) 20 mg capsules by Vanda Pharmaceuticals Inc. The label includes dosage instructions, storage conditions, and a barcode with NDC 43068-220-01. The text instructs to take 20 mg before bedtime without food. The label states 'Do not cover Braille' and notes the package contains 30 capsules.*

FDA Label Image

48 mL Bottle Label (Hetlioz 13)

Label for Hetlioz LQ (tasimelteon) oral suspension 4 mg/mL, 48 mL bottle. The label includes storage instructions to keep refrigerated at 5°C (41°F) with permitted excursions, directions for use with a dosing syringe adapter, Braille for the product name and strength, and identifies Vanda Pharmaceuticals Inc. as the distributor.*

FDA Label Image

48 mL Carton Label (Hetlioz 14)

Hetlioz LQ (tasimelteon) oral suspension 4 mg/mL packaging label showing a 48 mL prescription product by Vanda Pharmaceuticals Inc. The label includes dosing syringe and bottle adapter instructions, refrigeration storage details, and a requirement to shake well before use. The label emphasizes dispensing in the original container and provides preparation and usage instructions.*

FDA Label Image

158 mL Bottle Label (Hetlioz 15)

Hetlioz LQ (tasimelteon) oral suspension 4 mg/mL label. The label indicates Rx only, for oral use, and bottle volume of 158 mL. Storage instructions specify refrigeration between 2°C to 8°C (36°F to 46°F) with some temperature excursions allowed. The product is distributed by Vanda Pharmaceuticals Inc., Washington, DC. The label also includes instructions to dispense in original container, not cover the braille, and notes on dosage and preparation.*

FDA Label Image

158 mL Carton Label (Hetlioz 16)

Hetlioz LQ (tasimelteon) oral suspension 4 mg/mL packaging label from Vanda Pharmaceuticals Inc. The label states the product is for oral use only and includes preparation instructions, dosage recommendations, and storage conditions. The container size is 158 mL and it is Rx only. The label also lists included contents: a 158 mL bottle, an oral dosing syringe, and a press-in bottle adapter.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.